Why the Cannabis Sector is Ripe for More Mergers and Acquisitions
Palm Beach, FL –August 13, 2019 – The cannabis markets continue to grow globally and across the North American markets. In the U.S. with the possible legalization of recreational use on the radar, large marijuana companies are looking at a $22.7 billion national market by 2023… and Canada’s direct cannabis market is projected to double […]
Why a Former Kellogg President is Betting Big on CBD Growth
Palm Beach, FL – August 13, 2019 — Since the U.S. approved the 2018 Farm Bill, consumer demand for CBD has been explosive. So much so, 14% of Americans, or roughly one in seven now use some form of CBD for anxiety, insomnia, arthritis, migraines, and even stress. The Brightfield Group estimates the market to […]
Social Casino Gaming Market Revenues Growing at an Impressive Pace
Palm Beach, FL – August 13, 2019 – Today gaming is available to consumers at all times and over all devices. This year, more than 2.5 billion gamers across the world, will spend $152.1 billion on games in 2019, representing an increase of +9.6% year on year. An industry report projects that consumer spend on games will […]
Cancer Drug Sales Expected to Exceed $230 Billion by 2024
Palm Beach, FL –August 13, 2019 – For decades, big (and small) pharma companies have been trying to find ways to cure or at least devise better treatments for all types of cancers. While the war has not been won to find a cure, there have been many, many treatments and medications that can win […]
Choom to Acquire Ninetails Cannabis in Whitehorse, Yukon
Vancouver, BC – August 13, 2019 – Choom™ (CSE: CHOO) (OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that it has signed a purchase agreement (the “Agreement”) to acquire Ninetails Cannabis Inc. (“Ninetails”), a licensed cannabis retail store in […]
Moleculin Announces Completion of Lymphoma Trial Enrollment
Houston, TX – August 13, 2019 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its proof of concept clinical trial to evaluate its p-STAT3 inhibitor, WP1220, for the topical treatment of Cutaneous T-Cell Lymphoma (CTCL) […]
Tapinator, Inc. Reports Second Quarter 2019 Financial Results
Revenue grew 83% year-over-year to $1.3mm Category Leading Apps Revenue grew 282% year-over-year to $1.1mm Bookings grew 9% year-over-year to $967k Category Leading Apps Bookings grew 101% year-over-year to $566k Net loss decreased 52% year-over-year to $265k Adjusted EBITDA increased 2,781% year-over-year to $293k New York, NY – August 13, 2019 – Tapinator, […]
